INSIGHTS &
INDUSTRY NEWS

After years of uncertainty, hospice M&A has reached a clear inflection point. Q4 2025 marked the strongest transaction volume since 2021, driven by premium platform deals that reset valuation benchmarks and restored buyer confidence. As interest rates ease and the valuation gap narrows, private equity is deploying capital more aggressively. According to Cory Mertz, buyers are back—but the bar for clinical integrity and compliance has never been higher.

The recap of Home-Based Care M&A activity is now available in our M&A Report! Read all about the transactions that marked Q4 2025!

Mertz Taggart follows the publicly traded home-based care companies and reports on their earnings calls each quarter. Take a closer look at the M&A activity that marked Q3 2025.

The recap of Home-Based Care M&A activity is now available in our M&A Report! Read all about the transactions that marked Q2 2025!

Mertz Taggart follows the publicly traded home-based care companies and reports on their earnings calls each quarter.

The recap of Home-Based Care M&A activity is now available in our M&A Report! Read all about the transactions that marked Q2 2025!

A webinar series that bridges the gap between healthcare industry buyers and sellers by gathering valuable insights — helping owners understand what drives buyer interest and what may hold them back.

Mertz Taggart follows the publicly traded home-based care companies and reports on their earnings calls each quarter.

Discover key insights from Mertz Taggart’s April 10 panel on overcoming common challenges in home-based care M&A—what sellers must know to succeed.

The recap of Home-Based Care M&A activity is now available in our M&A Report! Read all about the transactions that marked Q1 2025!

Mertz Taggart follows the publicly traded home-based care companies and reports on their earnings calls each quarter.

The recap of Home-Based Care M&A activity is now available in our M&A Report! Read all about the transactions that marked Q4 2024!

Mertz Taggart follows the publicly traded home-based care companies and reports on their earnings calls each quarter.

The recap of Home-Based Care M&A activity is now available in our M&A Report! Read all about the transactions that marked Q3 2024!

Mertz Taggart follows the publicly traded home-based care companies and reports on their earnings calls each quarter.

After a historically slow first quarter that saw only 13 total deals in the home-based care space. Read all the details in our M&A report.

Mertz Taggart follows the publicly traded home-based care companies and reports on their earnings calls each quarter.

Mertz Taggart follows the publicly traded home-based care companies and reports on their earnings calls each quarter.

Q4 2023 saw a rise in home-based care deals with 25 transactions, marking a shift towards pre-pandemic activity levels.